Adverum Biotechnologies, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2013 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Adverum Biotechnologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q2 2024.
  • Adverum Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.95M, a 11.7% decline year-over-year.
  • Adverum Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $16.6M, a 11.4% decline year-over-year.
  • Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.6M, a 12.5% decline from 2022.
  • Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.1M, a 20.3% decline from 2021.
  • Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $25.2M, a 23.6% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $16.6M $3.95M -$524K -11.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $17.2M $4.17M -$397K -8.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $17.6M $4.15M -$1.11M -21% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-18
Q3 2023 $18.7M $4.39M -$114K -2.53% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $18.8M $4.47M -$473K -9.57% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $19.3M $4.56M -$818K -15.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $20.1M $5.25M +$843K +19.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $19.2M $4.5M -$823K -15.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $20.1M $4.94M -$3.29M -40% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $23.4M $5.38M -$1.84M -25.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $25.2M $4.41M -$1.77M -28.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $27M $5.33M -$694K -11.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $27.7M $8.23M +$3.45M +72.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $24.2M $7.22M +$3.82M +112% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $20.4M $6.18M +$3.33M +117% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-29
Q3 2020 $17.1M $6.02M +$3.36M +126% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $13.7M $4.79M +$2.16M +82.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $11.5M $3.41M +$1.65M +93.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $9.9M $2.85M +$1.67M +141% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $8.23M $2.66M -$335K -11.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $8.57M $2.63M -$3.2M -54.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $11.8M $1.76M -$1.67M -48.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-28
Q4 2018 $13.4M $1.18M -$703K -37.3% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $14.1M $3M +$296K +11% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $13.8M $5.83M +$3.58M +160% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $10.3M $3.43M +$1.53M +80.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $8.72M $1.88M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 $2.7M -$242K -8.23% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $2.24M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $1.9M -$2.19M -53.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q3 2016 $2.94M -$2.81M -48.9% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q1 2016 $14.8M $4.08M +$3.31M +428% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-06
Q4 2015 $11.5M $4.42M +$296K +7.18% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 $11.2M $5.75M +$2.7M +88.2% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $8.51M $559K -$712K -56% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $9.23M $773K +$658K +572% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $8.57M $4.13M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-04
Q3 2014 $3.06M +$2.94M +2604% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $1.27M +$1.15M +968% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 $115K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q3 2013 $113K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q2 2013 $119K Apr 1, 2013 Jun 30, 2013 10-Q 2014-09-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.